Stay updated on NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Sign up to get notified when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.
Latest website image capture
Clouds background image

Latest updates to the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page

  1. Check
    5 days ago
    Change Detected
    Summary
    The study history now shows that enrollment is closed (no longer looking for participants) and adds a new revision entry (v3.6.0), with the previous revision (v3.5.5) removed from the record.
    Difference
    0.2%
    Check dated 2026-06-13T17:05:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A new site revision label v3.5.5 was added, replacing the previous v3.5.4 in the record history. This indicates a minor system or UI update and does not change study data or content.
    Difference
    0.0%
    Check dated 2026-06-06T13:36:03.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    Two new history entries were added: 2026-05-28 labeled 'Study Status' and 2026-05-27 showing '64'. The 2026-02-03 entry was removed.
    Difference
    0.2%
    Check dated 2026-05-30T12:07:46.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    The page’s revision tag has been updated to v3.5.4, indicating a new build. This reflects an incremental release rather than content changes.
    Difference
    0.0%
    Check dated 2026-05-15T23:52:41.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page’s interface revision/version label was updated from “v3.5.2” to “v3.5.3,” indicating a minor update to the ClinicalTrials.gov site software rather than a change to the trial record content.
    Difference
    0.0%
    Check dated 2026-04-24T16:44:17.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T13:31:30.000Z thumbnail image

Stay in the know with updates to NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer

Enter your email address, and we'll notify you when there's something new on the NILE Clinical Trial: Durvalumab Combo in Unresectable Urothelial Cancer page.